Seeking Alpha

ICPT
  Intercept Pharmaceuticals - NASDAQ

8/23/2014, 3:38 AM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
ICPT vs. ETF Alternatives
Company Description
Intercept Pharmaceuticals Inc is a development stage, Biopharmaceutical Company engaged in the development and commercialization of novel therapeutics to treat chronic liver disease utilizing its proprietary bile acid chemistry.
Sector: Healthcare
Industry: Biotechnology
Country: United States